China's State Council issued new Anti-Monopoly Guidelines for the Pharmaceutical Sector (the "Guidelines") effective January 24, 2025. The ...

The Food and Drug Administration (FDA) is hoping a newly approved non-opioid pain medication could help save lives. Dr.

TFF Pharmaceuticals, Inc., currently trading at $43.30 per share and maintaining a solid financial health score of 2.73 on InvestingPro, has issued a new class of shares to ensure a quorum for an ...